Jun J. Ishikawa
Osaka, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 111 publications
Prognostic factors of second allogeneic hematopoietic stem cell transplantation for relapsed or refractory myelodysplastic syndromes: nationwide registry analysis.
Journal: Bone marrow transplantation
Published: May 19, 2026
Comparison of post-transplant cyclophosphamide and low-dose anti-thymocyte globulin with dose-dependent effects in mismatched unrelated donor transplantation.
Journal: British journal of haematology
Published: May 14, 2026
Valemetostat is efficacious against recurrent adult T cell leukemia/lymphoma skin lesions and cutaneous graft-versus-host disease.
Journal: Transplantation and cellular therapy
Published: March 25, 2026
Conditioning-adapted methotrexate in cord blood transplantation for high-risk acute myeloid leukemia: a nationwide Japanese cohort analysis.
Journal: Scientific reports
Published: March 16, 2026
Real-World Treatment Patterns and Outcomes of Patients With Acute Myeloid Leukemia in Japan in the Pre-venetoclax Era.
Journal: Clinical lymphoma, myeloma & leukemia
Published: February 16, 2026
Donor age as a dual-risk factor for donor safety and recipient survival in allogeneic haematopoietic stem cell transplantation.
Journal: British journal of haematology
Published: February 05, 2026
Dosing Subcutaneous Immunoglobulin to Achieve Target Levels in Hematopoietic Cell Transplant Recipients.
Journal: Blood cell therapy
Published: December 13, 2025
Impact of Total Body Irradiation Dose in Reduced-Intensity Conditioning for Allogeneic Hematopoietic Cell Transplantation in Acute Myeloid Leukemia.
Journal: American journal of hematology
Published: November 10, 2025
Application Timing-Dependent Impact of Donor Source on Outcomes After Allogeneic Hematopoietic Stem Cell Transplantation for Adult T-Cell Leukemia/Lymphoma.
Journal: Hematological oncology
Published: October 13, 2025
Secondary T-cell lymphoma arising from pre-existing clones in a patient with diffuse large B-cell lymphoma during epcoritamab treatment following CAR-T therapy.
Journal: Haematologica
Published: September 26, 2025
Risk Stratification Using Dynamic International Prognostic Scoring System and Splenomegaly in Myelofibrosis Treated with Pretransplant JAK Inhibitors.
Journal: Transplantation and cellular therapy
Published: July 21, 2025
Risk Factors for and Impact of Pre-Engraftment Syndrome on Outcomes Following Single-Unit Cord Blood Transplantation in Adults.
Journal: American journal of hematology
Published: July 06, 2025
Last Updated: 09/26/2026